What is Wilsons disease

Wilson’s disease is a rare, inherited genetic disorder that prevents the body from properly removing excess copper, leading to its toxic accumulation in the liver, brain, and other vital organs. If left untreated, the buildup of copper can cause severe, life-threatening damage, but early diagnosis and lifelong medical management allow most individuals to lead full and active lives.

What causes Wilson’s disease to develop?

Wilson’s disease is caused by mutations in the ATP7B gene, which is responsible for producing a protein that helps transport copper out of the liver and into the bile for excretion. When this gene does not function correctly, copper is not properly eliminated from the body. Instead, it accumulates in the liver initially, and as the liver’s storage capacity is exceeded, it spills over into the bloodstream and deposits in other organs, most notably the brain, kidneys, and eyes. This genetic condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene—one from each parent—to develop the disorder.

Which body systems are affected by Wilson’s disease?

The progression of Wilson’s disease varies significantly between patients, but it primarily impacts two major systems:

• Hepatic (Liver): The liver is the primary site of copper storage. Symptoms can range from asymptomatic liver enzyme elevation to chronic hepatitis, cirrhosis, or acute liver failure.


• Neurological and Psychiatric: When copper deposits in the brain, it can cause movement disorders (tremors, difficulty walking, or muscle stiffness) and psychiatric symptoms (depression, anxiety, or personality changes).


• Ocular (Eyes): A hallmark sign is the Kayser-Fleischer ring, a golden-brown or greenish ring around the iris caused by copper deposits in the cornea.

How common is Wilson’s disease and who does it affect?

Wilson’s disease is considered a rare condition, with an estimated global prevalence of approximately 1 in 30,000 to 1 in 50,000 people. Because it is a genetic disorder, it affects males and females equally across all ethnic and geographic groups. While the underlying genetic defect is present from birth, symptoms typically do not manifest until childhood, adolescence, or early adulthood—most commonly between the ages of 5 and 35. Currently, 161 people with Wilson’s disease have joined the DiseaseMaps.org community to share their experiences, highlighting the importance of peer support in navigating this lifelong condition.

How does Wilson’s disease differ from other liver or neurological conditions?

What sets Wilson’s disease apart from other conditions is its unique metabolic basis; unlike many liver diseases that respond to lifestyle changes or standard medications, this condition requires lifelong copper-chelating therapy or zinc supplementation. Furthermore, the presence of specific neurological symptoms combined with liver dysfunction in a young patient is a critical clinical "red flag" that distinguishes Wilson’s disease from other causes of hepatitis or movement disorders like early-onset Parkinson’s disease.

Next steps

• Consult a hepatologist or a neurologist with specific expertise in metabolic disorders to discuss diagnostic testing, such as ceruloplasmin levels and 24-hour urinary copper collection.


• Speak with a clinical geneticist to understand family screening options, as siblings of someone diagnosed with Wilson’s disease are at a higher risk and should be tested.


• Join the DiseaseMaps.org community to connect with others who are managing the daily realities of this condition.


• Adhere strictly to prescribed medical treatments, as medication non-compliance is the most common cause of symptom progression.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Wilson disease overview.


• Orphanet: Wilson disease (ORPHA:905).


• OMIM (Online Mendelian Inheritance in Man): ATP7B gene entry (#277900).


• Wilson Disease Association: Patient education and clinical resources.